STAT

Fitbits and other wearables may not accurately track heart rates in people of color

Many popular wearable heart rate trackers rely on technology that could be less accurate for consumers who have darker skin, researchers, engineers and other experts told STAT.

An estimated 40 million people in the United States have smartwatches or fitness trackers that can monitor their heartbeats. But some people of color may be at risk of getting inaccurate readings.

Nearly all of the largest manufacturers of wearable heart rate trackers rely on technology that could be less reliable for consumers who have darker skin, according to researchers, engineers, and other experts who spoke with STAT. Fitbit uses the potentially problematic technology in every heart rate tracker it offers, and it’s also in many Garmin and Samsung devices. Other popular trackers, like the Apple Watch, use it, too — but simultaneously track heart rates with another method.

The phenomenon has received almost no media attention, even as the market for smartwatches and fitness trackers has grown exponentially in recent years — and as both consumers and scientists have raised broader concerns about the trackers’ accuracy. There are a number of online complaints from consumers who suggest the devices can’t get a reading on darker skin. But the companies that make the devices don’t disclose the fact that they could be less accurate for some consumers.

The potential inaccuracies have broad implications for the growing body of scientific research that relies on these wearables — as well as for the increasing number of people whose employers offer financial incentives or other benefits for using Fitbits and other trackers.

Concerns about the devices also come amid a broader reckoning over whether new

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks